FDA.reportPublic FDA data

semaglutide 4 MG in 3 ML Pen Injector

RxCUI
2398841
RxNorm name
semaglutide 4 MG in 3 ML Pen Injector
Display name
semaglutide 4 MG in 3 ML Pen Injector
Full name
semaglutide 4 MG in 3 ML Pen Injector
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OzempicSEMAGLUTIDEA-S Medication Solutions979e4df4-0597-48ea-b51c-0f699fa6d1662023-11-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2398841

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
adec4fd2-6858-4c99-91d4-531f5f2a2d79semaglutide 4 MG in 3 ML Pen Injector [PSN] · 3 ML semaglutide 1.34 MG/ML Pen Injector [SCD] · semaglutide 4 MG in 3 ML Pen Injector [SY]319These highlights do not include all the information needed to use OZEMPIC ® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 201720260519
979e4df4-0597-48ea-b51c-0f699fa6d166semaglutide 4 MG in 3 ML Pen Injector [PSN] · 3 ML semaglutide 1.34 MG/ML Pen Injector [SCD] · semaglutide 4 MG in 3 ML Pen Injector [SY]33These highlights do not include all the information needed to use OZEMPIC ® safely and effectively. See full prescribing information for OZEMPIC. OZEMPIC (semaglutide) injection, for subcutaneous use Initial U.S. Approval: 201720231122